Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.7000
+0.0100 (1.45%)
Nov 20, 2025, 9:30 AM EST
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $1.87 million as of November 21, 2025. Its market cap has decreased by -80.90% in one year.
Market Cap
1.87M
Enterprise Value
2.45M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 1.87M, a decrease of -98.57%. That is a compound annual growth rate of -44.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 1.87M | -28.67% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | 46.34M | -35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Elite Pharmaceuticals | 621.43M |
| Glass House Brands | 434.20M |
| American Oncology Network | 412.69M |
| Northwest Biotherapeutics | 374.98M |
| CytoDyn | 372.76M |
| Silence Therapeutics | 318.83M |
| Nika Pharmaceuticals | 311.89M |